Vaginal pH and microbicidal lactic acid when lactobacilli dominate the microbiota

Lactic acid at sufficiently acidic pH is a potent microbicide, and lactic acid produced by vaginal lactobacilli may help protect against reproductive tract infections. However, previous observations likely underestimated healthy vaginal acidity and total lactate concentration since they failed to ex...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 8; no. 11; p. e80074
Main Authors O'Hanlon, Deirdre E, Moench, Thomas R, Cone, Richard A
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 06.11.2013
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Lactic acid at sufficiently acidic pH is a potent microbicide, and lactic acid produced by vaginal lactobacilli may help protect against reproductive tract infections. However, previous observations likely underestimated healthy vaginal acidity and total lactate concentration since they failed to exclude women without a lactobacillus-dominated vaginal microbiota, and also did not account for the high carbon dioxide, low oxygen environment of the vagina. Fifty-six women with low (0-3) Nugent scores (indicating a lactobacillus-dominated vaginal microbiota) and no symptoms of reproductive tract disease or infection, provided a total of 64 cervicovaginal fluid samples using a collection method that avoided the need for sample dilution and rigorously minimized aerobic exposure. The pH of samples was measured by microelectrode immediately after collection and under a physiological vaginal concentration of CO2. Commercial enzymatic assays of total lactate and total acetate concentrations were validated for use in CVF, and compared to the more usual HPLC method. The average pH of the CVF samples was 3.5 ± 0.3 (mean ± SD), range 2.8-4.2, and the average total lactate was 1.0% ± 0.2% w/v; this is a five-fold higher average hydrogen ion concentration (lower pH) and a fivefold higher total lactate concentration than in the prior literature. The microbicidal form of lactic acid (protonated lactic acid) was therefore eleven-fold more concentrated, and a markedly more potent microbicide, than indicated by prior research. This suggests that when lactobacilli dominate the vaginal microbiota, women have significantly more lactic acid-mediated protection against infections than currently believed. Our results invite further evaluations of the prophylactic and therapeutic actions of vaginal lactic acid, whether provided in situ by endogenous lactobacilli, by probiotic lactobacilli, or by products that reinforce vaginal lactic acid.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Competing Interests: DE O’Hanlon, TR Moench, and RA Cone have applied for the following patents: Compositions and Methods for Inactivation of Pathogens at Genital Tract Surfaces (U.S. Patent Application Number 20120070476), and Reusable Intravaginal Delivery Device, System, and Method (U.S. Patent Application Number 20120296315), with patent assignment to ReProtect Inc., Baltimore MD., and John Hopkins University, Baltimore MD. RA Cone and TR Moench are employed by ReProtect Inc. (Chair of the Board, and President/Chief Operating Officer respectively) and hold equity in the company. This does not alter our adherence to all the PLoS One policies on sharing data and materials.
Conceived and designed the experiments: DOH RAC TRM. Performed the experiments: DOH. Analyzed the data: DOH. Wrote the manuscript: DOH TRM RAC.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0080074